CD8A and colorectal carcinoma: Consistent with previous study, a significantly higher level of circulating PD-1+ cells on CD8+ T cells in CRC patients were observed compared with normal volunteers (median, 13.45% vs 8.3%; p = 0.0021, Figure 1E).